english.prescrire.org > Topics > Advancing healthcare policy > Transparent, independent health authorities > The worldwide debate on access to data

Advancing healthcare policy

Transparent, independent health authorities

Transparent, independent health authorities: The worldwide debate on access to clinical trial data

From around 2010 on, the debate around public access to clinical trial data has intensified. In order to block transparency, pharmaceutical companies often invoke  notions of intellectual property.